Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Laura Tang

3PUBLICATIONS
31CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jun 26, 2026
Peripheral Th17 immune signature associates with excellent response to anti-PD1/anti-PD-L1 therapy across solid tumors.

|Mar 27, 2025
Anti-CTLA4 Therapy Leads to Early Expansion of a Peripheral Th17 Population and Induction of Th1 Cytokines.

Mari Nakazawa, Soren Charmsaz, Elsa Hallab

|Aug 19, 2018
Current and Investigational Agents Targeting the Phosphoinositide 3-Kinase Pathway.

Laura A Tang, Brianne N Dixon, Kathryn T Maples

Pageof 1

Frequent Collaborators

2 joint publications

Mari Nakazawa

2 joint publications

Soren Charmsaz

2 joint publications

Jeannie Hoffman-Censits

2 joint publications

Chester Kao

2 joint publications

Madelena Brancati

2 joint publications

Yasser Ged

2 joint publications

Howard L Li

2 joint publications

James M Leatherman

2 joint publications

Evan J Lipson

2 joint publications

Christopher Thoburn

Frequent Collaborators

2 joint publications

Mari Nakazawa

2 joint publications

Soren Charmsaz

2 joint publications

Jeannie Hoffman-Censits

2 joint publications

Chester Kao